Polar Asset Management Partners’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-27,389
Closed -$497K 624
2025
Q1
$497K Sell
27,389
-110,161
-80% -$2.46M 0.01% 335
2024
Q4
$3.48M Buy
137,550
+127,850
+1,318% +$3.47M 0.04% 274
2024
Q3
$330K Sell
9,700
-1,900
-16% -$72.4K 0.01% 475
2024
Q2
$429K Buy
11,600
+1,800
+18% +$67.9K 0.01% 434
2024
Q1
$411K Sell
9,800
-84,500
-90% -$3.47M 0.01% 474
2023
Q4
$3.74M Sell
94,300
-38,100
-29% -$1.12M 0.06% 264
2023
Q3
$3.64M Buy
+132,400
New +$4.15M 0.08% 284
2022
Q3
Sell
-98,600
Closed -$2.66M 1410
2022
Q2
$2.66M Buy
98,600
+29,400
+42% +$854K 0.03% 647
2022
Q1
$2.36M Buy
+69,200
New +$2.21M 0.03% 603

Other funds holding CLDX